TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
PCRX

Pacira BioSciences, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

36.30$ -0.2% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

Pacira BioSciences, Inc. (PCRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,244 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PCRX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
381 391 600 606 606 628 622 643 659 689 719 788 807 831 821 866 1,220 1,275 1,288 1,326 1,356 2,075 1,891 1,734 1,734 1,681 1,523 1,542 1,534 1,574 1,583 1,647 1,522 1,554 1,587 1,537 1,298 1,265 1,209 1,244
235 243 448 451 366 391 419 455 472 478 509 395 379 409 432 456 659 652 720 793 822 866 667 526 533 498 376 429 447 510 543 632 690 745 760 746 563 548 515 615
24 36 109 54 26 54 42 117 231 133 215 60 85 78 55 79 125 100 67 106 134 586 227 122 109 104 36 87 99 153 184 247 246 277 284 300 148 159 144 206
161 173 384 382 294 311 340 371 386 383 412 292 266 292 318 327 532 522 590 647 694 656 452 316 329 289 174 221 235 279 326 404 454 485 494 446 246 238 202 251
27 30 28 27 27 32 31 36 34 38 40 41 43 48 39 44 46 53 53 68 50 96 93 91 93 98 93 99 97 106 102 105 101 113 105 114 115 124 126 132
37 31 30 34 39 41 40 42 45 49 47 53 60 58 60 67 69 65 65 65 67 99 104 101 97 96 93 92 97 104 97 103 112 125 134 148 158 153 150 135
100 101 103 103 106 107 109 111 110 109 107 105 105 105 108 113 126 137 145 225 159 265 190 191 194 254 182 180 – – – – – – – – – – – –
45 47 49 51 53 55 57 60 62 62 62 101 100 100 100 100 100 100 100 100 100 145 146 146 157 163 163 163 163 163 163 163 0.0 0.0 22 20 20 20 20 20
45 47 49 51 53 55 57 60 62 – – 108 106 104 102 100 98 97 95 93 91 624 610 595 581 541 526 512 498 483 469 455 440 426 435 423 382 368 353 285
167 172 329 345 341 349 344 352 358 368 392 446 461 476 447 478 636 655 637 639 637 1,345 1,182 977 964 906 755 734 703 704 691 768 772 775 788 779 570 572 555 572
147 45 46 58 52 56 48 53 55 61 59 83 96 108 80 71 86 253 232 229 226 521 305 133 132 148 99 109 94 97 93 93 306 310 315 313 107 121 109 122
108 109 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 5.6 6.2 5.0 4.9 4.0 7.6 7.5 157 157 159 162 383 202 42 42 43 20 28 17 17 18 9.1 211 211 211 212 9.7 9.8 9.8 10
7.3 7.5 9.4 10 12 15 15 14 14 14 13 13 16 13 16 9.2 13 10 9.1 12 7.9 11 15 14 13 15 17 24 17 16 9.0 19 19 19 23 30 18 15 14 18
0.0 109 266 269 273 276 280 283 287 291 294 298 302 306 310 314 456 313 317 322 326 675 327 318 714 656 543 532 516 514 512 589 386 384 381 378 377 372 368 363
214 219 271 261 265 279 279 291 301 321 328 342 346 355 374 388 585 620 651 687 719 730 710 757 770 775 768 808 832 870 892 879 750 778 799 758 727 693 654 672
-342 -346 -366 -386 -394 -389 -398 -396 -397 -388 -391 -388 -395 -399 -391 -399 -268 -254 -244 -224 -207 -212 -158 -138 -139 -149 -168 -143 -132 -107 -98 -79 -222 -206 -202 -206 -201 -199 -196 -192
37 37 38 40 40 42 41 42 41 42 41 42 42 42 43 42 44 45 46 46 45 45 46 52 46 46 46 52 52 52 52 51 46 49 47 45 44 43 41 40

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?